senateStanding
Finance Committee
- Referred To
← Back to federal legislation0 ratings0 comments
S. 229In committee
DTC Act of 2025
Introduced: Jan 23, 2025
Latest action date: Jan 23, 2025
Latest development
Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
Civixly approval
No ratings yet
Not enough ratings yet. Public approval appears at 5+ ratings.
Your view
- Congress
- 119th Congress
- Introduced
- Jan 23, 2025
- Recorded roll calls
- 0
Status detail: The most advanced recorded stage is committee consideration.
Plain-language overview
What this bill does
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025
This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.
Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.
The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Official summary from Congress.gov.
Civixly topics
What this legislation is about
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Health
View 6 official legislative subjects
Administrative law and regulatory proceduresCivil actions and liabilityDepartment of Health and Human ServicesHealth care costs and insuranceMarketing and advertisingPrescription drugs
Committee activity
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Official committee record ↗
Amendments
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Oct 20, 2026.
Action timeline
Newest action first. Action language comes from the official Congress.gov record.
View full action timeline2 actions
Introduced in Senate
IntroReferralLibrary of CongressRead twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
IntroReferralSenate
Roll-call votes
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
Discussion
0 comments across 0 threads
Sign in to join the discussion.Comments are publicly visible.
Loading comments...